UK Public Sector Contracts & Tenders

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 MSK Services to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months, from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £1,063,075.

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 MSK Services to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months, from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £3,019,454.

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Endoscopy Services to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months, from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £2,381,000.

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Endoscopy Services to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months, from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £1,323,000.

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Dermatology Services to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months, from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £809,230.

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver the provision of Improving Access to Phycological Therapies (IAPT) for Mid and South Essex to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £2,884,013.00 As of July 2022, the Integrated Care Board (ICB) superseded the previous 5 CCGs within Mid and South Essex. NHS Mid and South Essex ICB is currently undergoing an organisational restructure and have taken the decision to extend the current contract to the incumbent provider for 12 months whilst commissioning decisions and strategies can be made for the future of this service. The Authority considers this provider for this IPCC SMI service as technically capable of providing the most economically advantageous solution to the Authority whilst the ICB undergoes restructure, review and alignment of contracts. The Authority is applying the NHS Standard Contract Terms and Conditions to ensure appropriate clinical governance and service delivery quality as well as consistency of service to patients. This notice is being published to reflect the date by which the Authority has satisfied it's internal governance process and the Authority's signatures have been ascertained, not at the time of the proposed start-date of this contract. The Authority will observe a 10-day standstill from the date of publication of this notice. The Authority will publish appropriate Notices accordingly to communicate any such future changes and opportunities to the market, once final.

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Integrated Primary Community Care (IPCC) Severe Mental Illness (SMI) for Mid and South Essex to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £1,329,439.00 As of July 2022, the Integrated Care Board (ICB) superseded the previous 5 CCGs within Mid and South Essex. NHS Mid and South Essex ICB is currently undergoing an organisational restructure and have taken the decision to extend the current contract to the incumbent provider for 12 months whilst commissioning decisions and strategies can be made for the future of this service. The Authority considers this provider for this IPCC SMI service as technically capable of providing the most economically advantageous solution to the Authority whilst the ICB undergoes restructure, review and alignment of contracts. The Authority is applying the NHS Standard Contract Terms and Conditions to ensure appropriate clinical governance and service delivery quality as well as consistency of service to patients. This notice is being published to reflect the date by which the Authority has satisfied it's internal governance process and the Authority's signatures have been ascertained, not at the time of the proposed start-date of this contract. The Authority will observe a 10-day standstill from the date of publication of this notice. The Authority will publish appropriate Notices accordingly to communicate any such future changes and opportunities to the market, once final.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Endoscopy Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-032164) on the 31st October 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante transparency notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Authority intends to enter into a contract for 6 months, with the option to extend for a further 6 months, from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £2,381,000.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Endoscopy Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-032165) on the 31st October 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante transparency notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Authority intends to enter into a contract for 6 months, with the option to extend for a further 6 months, from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £1,323,000.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Autism Spectrum Disorder (ASD) Assessments to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-032173) on the 31st October 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 ("PCR 2015") (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante transparency notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The contract will be for 12 months from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £716,895.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 MSK Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-032169) on the 31st October 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante transparency notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Authority intends to enter into a contract for 7 months, with the option to extend for a further 5 months, from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £1,063,075.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 MSK Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-032170) on the 31st October 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante transparency notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Authority intends to enter into a contract for 7 months, with the option to extend for a further 5 months, from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £3,019,454.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Dermatology Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-032162) on the 31st October 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Authority intends to enter into a contract for 6 months, with the option to extend for a further 6 months, from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £1,027,687.

NHS Mid and South Essex Integrated Care Board have re-awarded an urgent contract for a 6 month extension for the provision of Community Dermatology and Tele dermatology Virtual Triage and Photography Clinics. This includes delivering the main element of Community Dermatology by the existing main provider- Mayflower Healthcare Alliance Limited and the Tele dermatology Virtual Triage and Photography Clinics Service sub contracting arrangements for the existing sub contract provider ICS Operations Trading as (Xyla) for the Tele dermatology Virtual Triage and Photography Clinics Service. This is under Regulation 14 of the Health Care Services (Provider Selection Regime) Regulations 2023 (PSR 23). This is for a period of 6 months from the 01st October 2025 to the 31th March 2026 as the current Procurement timeline has slipped this urgent award to allow both incumbent providers to continue whilst the mobilisation is undertaken- to ensure continuity and patient safely. This notice is confirmation of an award having been made due to an urgent circumstance and delaying the award of the contract was considered as having been likely to pose a risk to patient or public safety and to protect the health of these patients. The contract is awarded for both providers 1st October 2025 - 31st March 2026. The estimated contract value is for the 6 months is £415,970.80 with a 3-month notice period for Mayflower Healthcare Alliance Limited and £754,752.00 for ICS Operations Trading as (Xyla). The total value for both services is £1170722.80.

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Autism Spectrum Disorder (ASD) Assessments to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £716,895. As of July 2022, the Integrated Care Board (ICB) superseded the previous 5 CCGs within Mid and South Essex. NHS Mid and South Essex ICB is currently undergoing an organisational restructure and have taken the decision to extend the current contract to the incumbent provider for 12 months whilst commissioning decisions and strategies can be made for the future of this service. The Authority considers this provider for this Autism Spectrum Disorder (ASD) Assessments service as technically capable of providing the most economically advantageous solution to the Authority whilst the ICB undergoes restructure, review and alignment of contracts. The Authority is applying the NHS Standard Contract Terms and Conditions to ensure appropriate clinical governance and service delivery quality as well as consistency of service to patients. This notice is being published to reflect the date by which the Authority has satisfied it's internal governance process and the Authority's signatures have been ascertained, not at the time of the proposed start-date of this contract. The Authority will observe a 10-day standstill from the date of publication of this notice. The Authority will publish appropriate Notices accordingly to communicate any such future changes and opportunities to the market, once final.

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 MSK Services to the patients within Mid and South Essex's geographical footprint. The contract will be for 7 months, with the option to extend for a further 5 months, from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £3,019,454.

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 MSK Services to the patients within Mid and South Essex's geographical footprint. The contract will be for 7 months, with the option to extend for a further 5 months, from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £1,063,075.

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract the 39 General Practitioners (GPs) for the provision of "Locally Enhanced Services (LES)" for the patient population within Mid Essex geographical footprint. The contract will be for 12 months, from 01st April 2023 - 31st March 2024 . The aggregate contract value across the 39 service providers is forecasted at £2,083,576.